Defining new strategies for therapy in PRKAG2 mutations and hypertrophic cardiomyopathy: implications for personalised medicine in inherited cardiac disorders


Introduction PRKAG2 cardiomyopathies  are autosomal dominant inherited  heart muscle diseases often characterized by left ventricular hypertrophy (LVH), progressive conducting abnormalities and ventricular pre-excitation... [ view full abstract ]


  1. Rameen Shakur (University of Cambridge)
  2. Juned Kadiwala (University of Cambridge)
  3. Robert Lowe (universtity of london, QMUL)

Topic Areas

Integrating Big Data (genome data, pharmacogenomics, therapeutic applications of genome ed , Drug target discovery and integration with individualized therapy, integration of diagnosi , Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, et


OS2a-A » Multi-Topics (13:45 - Tuesday, 26th June, Amphitheater)

Presentation Files

The presenter has not uploaded any presentation files.